Since LPS-induced NLRP3 inflammasome activation plays a critical role in the tumorigenesis of NSCLC [10, 13], we investigated the effects of SAL on the NLRP3 inflammasome in LPS-treated A549 cells. Here, NLRP3 is linked to non-small cell lung carcinoma.